
SPPS, purification, and lyophilization typically produce a white powder. This must now be subjected to detailed analysis (quality control, QC) to find answers to the following questions:
Our QC departments have a huge arsenal of equipment and methods at their disposal to analyze our products. The choice of analytical methods also depends on the nature of the product — that is, whether it is an amino acid, a very short peptide, or a longer peptide.
If it is the desired product, the measured values should correspond to those in the literature or the values obtained for a reference sample. The following parameters are used to demonstrate identity:
Purity can be evaluated by various methods:
In addition to impurities arising during the synthesis, the lyophilized products typically contain trace amounts of residual solvents and/or water. Most peptides also contain trifluoroacetic acid or acetic acid, which is firmly bound to the free N-terminus and basic side-chain functionalities (e.g., Arg, Lys, His) as the salt.
These compounds are not measured by the same methods used to determine the purity of the desired product. In order to calculate the amount of each component needed in a reaction mixture, for example, parameters such as the peptide content and water content must be known. These are evaluated by various techniques:
As such, the “net peptide content” (NPC) is defined as the percentage of peptides relative to non-peptidic material (mostly counterions and moisture). NPC and purity are not equivalent, because the former includes peptidic contaminants. In addition, a low NPC must be expected for peptides containing a large proportion of basic amino acids, even if they are extremely pure, owing to salt formation. This is also the case for hydrophilic peptides, which can absorb considerable amounts of moisture. Both the NPC and the purity must be taken into consideration when preparing solutions of biologically active peptides for assays.
A selection of the obtained results can be found on the Analytical Data Sheet (ADS) or Certificate of Analysis (CofA), which is made available to customers who purchase our products. In the case of GMP products, microbiological analyses are added that are performed in a specialized laboratory at Bachem. For many of our generics, the analyses to be undertaken are specified by the European Pharmacopoeia*. “Ph. Eur.” in the name signifies that a drug substance conforms to the specifications of the pharmacopoeia (e.g., “desmopressin acetate Ph. Eur.”).
The purity of a peptide can vary from batch to batch, affecting the proportion of the desired product. For example, when a peptide is ordered at 80% purity, the quality can range from 80% to 100%. The variability is more noticeable when requesting lower purity levels. Consequently, quantitative assay results can fluctuate unpredictably, depending on the batch quality.
Batches with low purity may contain various peptidic by-products, which can differ in both proportion and structure. While some of these impurities might exhibit biological activity, it is not necessarily the same as the activity of the target peptide. In some cases, these by-products can interfere with assays.
The Net Peptide Content can vary based on several factors, including peptide polarity, lyophilization process, storage conditions, and exposure to humidity. For accurate biological assays, unpurified peptides should not be used, as they may still contain harmful non-peptidic impurities such as small amounts of scavengers.
Peptides purified through standard methods and lyophilized generally contain only trace amounts of cytotoxic non-peptidic contaminants, like residual solvents and scavengers. However, TFA (Trifluoroacetic acid) cannot be completely removed due to salt formation. If residual TFA is a concern, ordering a more biocompatible salt form of the active peptide may be advisable. Keep in mind that this will require an additional ion exchange step and an adjusted price for the custom peptide.
Four standard product grades are offered by Bachem (see Table 15), and intermediate purity ranges can be provided on demand. The lower the required level of purity, the lower the price will be. The correlation between purity and price is not linear, however. Efforts and costs for obtaining very pure peptides (97–99%) may increase exponentially.
| Purity | Applications |
|---|---|
| >95% | • NMR studies • Crystallography studies • Peptides used as a reference in final quantitative studies: * Enzyme–substrate studies * Receptor–ligand interaction studies * Blocking and competition assays |
| 90–95% | • Production of monoclonal antibodies • Enzyme–substrate studies (quantitative) • Receptor–ligand interaction studies (quantitative) • Blocking and competition assays (quantitative) • Immunoassays (quantitative) • In vivo/in vitro studies |
| >80% | • Western blotting studies (qualitative) • Enzyme–substrate studies (qualitative) • Phosphorylation studies |
| Immunograde (>65%) | • Production of polyclonal antibodies • Determination of antibody titer in standard immunoassays |
Table 15: Product grades offered by Bachem and recommended applications


